These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26613660)

  • 1. How should we use anti-CTLA-4 antibodies?
    Marabelle A; Eggermont A
    Eur J Cancer; 2015 Nov; 51(17):2686-8. PubMed ID: 26613660
    [No Abstract]   [Full Text] [Related]  

  • 2. [When CRAF takes over BRAF in melanoma].
    Dumaz N; Bagot M; Bensussan A
    Med Sci (Paris); 2011 Oct; 27(10):817-9. PubMed ID: 22027417
    [No Abstract]   [Full Text] [Related]  

  • 3. Newer developments in the immunotherapy of malignant melanoma.
    Maslin B; Alexandrescu DT; Ichim TE; Dasanu CA
    J Oncol Pharm Pract; 2014 Feb; 20(1):3-10. PubMed ID: 23435643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The conquest of melanoma by immunotherapy.
    Lejeune FJ
    Melanoma Res; 2015 Oct; 25(5):373-5. PubMed ID: 26173006
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic use of anti-CTLA-4 antibodies.
    Blank CU; Enk A
    Int Immunol; 2015 Jan; 27(1):3-10. PubMed ID: 25038057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of patients with metastatic melanoma.
    Yu Z; Si L
    Chin Clin Oncol; 2017 Apr; 6(2):20. PubMed ID: 28482673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma immunotherapy: historical precedents, recent successes and future prospects.
    Raaijmakers MI; Rozati S; Goldinger SM; Widmer DS; Dummer R; Levesque MP
    Immunotherapy; 2013 Feb; 5(2):169-82. PubMed ID: 23413908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMMUNOTHERAPY. Could microbial therapy boost cancer immunotherapy?
    Snyder A; Pamer E; Wolchok J
    Science; 2015 Nov; 350(6264):1031-2. PubMed ID: 26612936
    [No Abstract]   [Full Text] [Related]  

  • 9. Breakthrough of the year 2013. Cancer immunotherapy.
    Couzin-Frankel J
    Science; 2013 Dec; 342(6165):1432-3. PubMed ID: 24357284
    [No Abstract]   [Full Text] [Related]  

  • 10. Current and Emerging Perspectives on Immunotherapy for Melanoma.
    Daud A
    Semin Oncol; 2015 Dec; 42 Suppl 3():S3-S11. PubMed ID: 26598057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory Monoclonal Antibodies and Immunomodulation: Harvesting the Crop.
    Berraondo P; Ochoa MC; Rodriguez-Ruiz ME; Minute L; Lasarte JJ; Melero I
    Cancer Res; 2016 May; 76(10):2863-7. PubMed ID: 27308833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The perspective of immunotherapy: new molecules and new mechanisms of action in immune modulation.
    Blank CU
    Curr Opin Oncol; 2014 Mar; 26(2):204-14. PubMed ID: 24424272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CTLA-4 therapy may have mechanisms similar to those occurring in inherited human CTLA4 haploinsufficiency.
    Bakacs T; Mehrishi JN
    Immunobiology; 2015 May; 220(5):624-5. PubMed ID: 25638260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutations and immunotherapy outcome with CTLA-4 blockade in melanoma.
    Boussiotis VA
    N Engl J Med; 2014 Dec; 371(23):2230-2. PubMed ID: 25409261
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease.
    Marthey L; Mateus C; Mussini C; Nachury M; Nancey S; Grange F; Zallot C; Peyrin-Biroulet L; Rahier JF; Bourdier de Beauregard M; Mortier L; Coutzac C; Soularue E; Lanoy E; Kapel N; Planchard D; Chaput N; Robert C; Carbonnel F
    J Crohns Colitis; 2016 Apr; 10(4):395-401. PubMed ID: 26783344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained clinico-radiologic response to anti-cytotoxic T lymphocyte antigen 4 antibody therapy in metastatic myxoid liposarcoma.
    Dasanu CA
    J Oncol Pharm Pract; 2017 Oct; 23(7):549-551. PubMed ID: 27511215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-CTLA-4 monoclonal antibody: a major step in the treatment of metastatic melanoma].
    Robert C; Mateus C
    Med Sci (Paris); 2011 Oct; 27(10):850-8. PubMed ID: 22027422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies.
    Komatsubara KM; Carvajal RD
    Curr Oncol Rep; 2017 Jul; 19(7):45. PubMed ID: 28508938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QnAs with James Allison.
    Nair P
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9131-2. PubMed ID: 27506789
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ctla-4 blockade: a new hope for the immunotherapy of malignant melanoma].
    Lotem M; Merims S; Frank S; Ospovat I; Peretz T
    Harefuah; 2012 Oct; 151(10):585-8, 604. PubMed ID: 23316667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.